{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:53:21Z","timestamp":1791222801799,"version":"4.1.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T00:00:00Z","timestamp":1361404800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0057580","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T18:44:55Z","timestamp":1361472295000},"page":"e57580","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Single CD4 Test with 250 Cells\/Mm3 Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria"],"prefix":"10.1371","volume":"8","author":[{"given":"Charles F.","family":"Gilks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Munderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cissy","family":"Kityo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Katabira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth L.","family":"Goodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Grosskurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mugyenyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the DART Virology Group and Trial Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"CF Gilks","year":"2006","journal-title":"Lancet"},{"key":"ref2","article-title":"Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2010 revision","year":"2010","journal-title":"WHO Geneva"},{"key":"ref3","unstructured":"Abongomera G, Namata H, Nkhata M, Muzambi M, Seeley J, <etal>et al<\/etal>.. (2012) Lablite: baseline mapping survey of decentralised ART service provision in Malawi, Uganda and Zimbabwe. XIX International AIDS Conference. Washington DC, USA, 22\u201327 July.Abstract LBPE57."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(09)62067-5","article-title":"Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/QAD.0b013e3282f2d760","article-title":"Fixed duration interruptions are inferior to continuous treatment in African adults starting therapy with CD4 cell counts &lt; 200 cells\/microl","volume":"22","year":"2008","journal-title":"Aids"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-3156.2007.01973.x","article-title":"Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine\/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA)","volume":"13","year":"2008","journal-title":"Trop Med Int Health"},{"key":"ref7","unstructured":"Gilks CF, Walker AS, Dunn DT, Gibb DM, Ben Kikaire B, <etal>et al<\/etal>.. (in press) Lopinavir\/ritonavir monotherapy after 24 weeks of second-line anti-retroviral therapy in Africa: a randomised controlled trial (SARA) Antivir Ther."},{"key":"ref8","unstructured":"Mambule I, Walker AS, Reid A, Ssali F, Munderi P, <etal>et al<\/etal>.. (2011) Second-line boosted protease-containing therapy: assessing the impact of maintaining 3TC vs switching to ddI in addition to 2 drugs from new classes in a randomized comparison. 18th Conference on Retroviruses and Opportunistic Infections.Boston, 27 Feb-2 Mar (Abstract 541)."},{"key":"ref9","article-title":"Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach","year":"2006","journal-title":"WHO Geneva"},{"key":"ref10","unstructured":"Government of Malawi Ministry of Health (2011) Quarterly HIV Programme Report."},{"key":"ref11","article-title":"Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study","author":"IV Jani","year":"2011","journal-title":"Lancet"},{"key":"ref12","unstructured":"World Health Organisation (2011) HIV treatment reaching 6.6 million people, but majority still in need."},{"key":"ref13","article-title":"Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe","author":"A Medina Lara","journal-title":"PlosONE"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/QCO.0b013e3283423e0e","article-title":"Monitoring of highly active antiretroviral therapy in HIV infection","volume":"24","author":"AS Walker","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1473-3099(11)70168-2","article-title":"Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110\/ESTHER): a randomised non-inferiority trial","volume":"11","author":"C Laurent","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"d6792","DOI":"10.1136\/bmj.d6792","article-title":"Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial","volume":"343","author":"J Mermin","year":"2011","journal-title":"BMJ"},{"key":"ref17","unstructured":"Jourdain G, Ngo-Giang-Huong N, S Le Coeur S, Traisaithit P, Barbier S, <etal>et al<\/etal>.. (2011) PHPT-3: a randomized clinical trial comparing CD4 vs viral load ART monitoring\/switching strategies in Thailand. 18th Conference on Retroviruses and Opportunistic Infections. Boston, 27 Feb-2 Mar (Abstract 44)."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"d6884","DOI":"10.1136\/bmj.d6884","article-title":"CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study","volume":"343","author":"JG Kahn","year":"2011","journal-title":"BMJ"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/j.1365-3156.2009.02309.x","article-title":"Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria","volume":"14","author":"JJ van Oosterhout","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/600396","article-title":"Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings","volume":"49","author":"R Kantor","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAI.0b013e318186eb18","article-title":"CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy","volume":"49","author":"DM Moore","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/QAD.0b013e3283262a78","article-title":"Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda","volume":"23","author":"SJ Reynolds","year":"2009","journal-title":"AIDS"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1086\/648444","article-title":"Viremia, resuppression, and time to resistance in human immunodeficiency virus (HIV) subtype C during first-line antiretroviral therapy in South Africa","volume":"49","author":"CJ Hoffmann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/QAD.0b013e328270b877","article-title":"Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score","volume":"21","author":"A Mocroft","year":"2007","journal-title":"Aids"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/QAI.0b013e3181ec28ff","article-title":"A CD4+ cell count &lt;200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression","volume":"55","author":"MR Loutfy","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref26","unstructured":"Brennan A, Maskew M, MacPhail P, Sanne I, Fox M (2011) Examining the interaction between current CD4 cell count, current viral load suppression, and time on ART and mortality. 18th Conference on Retroviruses and Opportunistic Infections. Boston, 27 Feb-2 Mar (Abstract 555)."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0057580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T20:38:04Z","timestamp":1540240684000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0057580"}},"subtitle":[],"editor":[{"given":"Sean","family":"Emery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,21]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0057580","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,21]]}}}